• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经动脉化疗栓塞联合载药微球治疗肝细胞癌后出现持续性多器官缺血。

Sustained multiple organ ischaemia after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.

作者信息

Kim Young Woon, Kwon Jung Hyun, Nam Soon Woo, Jang Jeong Won, Jung Hyun Suk, Shin Yu Ri, Park Eun Su, Shim Dong Jae

机构信息

Department of Internal Medicine, Division of Hepatology, Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon 21431, Republic of Korea.

Department of Internal Medicine, Division of Hepatology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea.

出版信息

Exp Ther Med. 2018 Feb;15(2):1479-1483. doi: 10.3892/etm.2017.5540. Epub 2017 Nov 22.

DOI:10.3892/etm.2017.5540
PMID:29434732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5774377/
Abstract

Transarterial chemoembolization (TACE) with drug-eluting beads (DC beads) may enhance drug delivery to tumours and reduce systemic toxicity. TACE with DC beads leads to significantly fewer serious side-effects compared with conventional TACE. A 66-year-old man with hepatocellular carcinoma (HCC) complained of continuous abdominal pain 1 month after TACE with DC beads. At the time of TACE, angiography revealed severe stenosis of both hepatic arteries. The diagnostic work up on admission suggested severe bile duct injury with regional bile duct dilatation, segmental liver and spleen infarction, necrotizing pancreatitis, as well as gastric and duodenal ulcers. The pathology specimens of the duodenum contained DC beads that had passed through small vessels in the connective tissue. The patient's condition appeared to improve after 2 weeks of antibiotic treatment and supportive care, but new multifocal liver and spleen infarction subsequently developed. After 2 months, he was well enough to be discharged. His HCC partially responded to the TACE with DC beads but eventually progressed and he died after 11 months. The present case report highlights unexpected ongoing multiple organ ischaemia in a 66-year-old man treated for HCC using TACE with DC beads. The use of TACE with DC beads should be carefully considered in patients with vascular strictures or aberrant blood supply.

摘要

经动脉化疗栓塞术(TACE)联合载药微球(DC微球)可增强药物向肿瘤的递送并降低全身毒性。与传统TACE相比,TACE联合DC微球导致的严重副作用明显更少。一名66岁的肝细胞癌(HCC)男性患者在接受TACE联合DC微球治疗1个月后出现持续性腹痛。在TACE时,血管造影显示双侧肝动脉严重狭窄。入院时的诊断检查提示严重胆管损伤伴局部胆管扩张、节段性肝脾梗死、坏死性胰腺炎以及胃和十二指肠溃疡。十二指肠病理标本中含有通过结缔组织中小血管的DC微球。经过2周的抗生素治疗和支持治疗后,患者病情似乎有所改善,但随后出现了新的多灶性肝脾梗死。2个月后,他康复出院。他的HCC对TACE联合DC微球治疗部分缓解,但最终病情进展,11个月后死亡。本病例报告强调了一名66岁接受TACE联合DC微球治疗HCC的男性患者出现意外的持续性多器官缺血。对于有血管狭窄或异常血供的患者,应谨慎考虑使用TACE联合DC微球。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910c/5774377/bcbe5f802205/etm-15-02-1479-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910c/5774377/ea1739a35d7e/etm-15-02-1479-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910c/5774377/ed1eefae0310/etm-15-02-1479-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910c/5774377/c4efdc70d130/etm-15-02-1479-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910c/5774377/bcbe5f802205/etm-15-02-1479-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910c/5774377/ea1739a35d7e/etm-15-02-1479-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910c/5774377/ed1eefae0310/etm-15-02-1479-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910c/5774377/c4efdc70d130/etm-15-02-1479-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910c/5774377/bcbe5f802205/etm-15-02-1479-g03.jpg

相似文献

1
Sustained multiple organ ischaemia after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.经动脉化疗栓塞联合载药微球治疗肝细胞癌后出现持续性多器官缺血。
Exp Ther Med. 2018 Feb;15(2):1479-1483. doi: 10.3892/etm.2017.5540. Epub 2017 Nov 22.
2
Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma.肝细胞癌中使用载药微球的经动脉化疗栓塞术
World J Gastroenterol. 2016 Oct 28;22(40):8853-8861. doi: 10.3748/wjg.v22.i40.8853.
3
Acute necrotizing pancreatitis as a fatal complication following DC Bead transcatheter arterial chemoembolization for hepatocellular carcinoma: A case report and review of the literature.经导管动脉化疗栓塞术(使用DC Bead)治疗肝细胞癌后发生急性坏死性胰腺炎作为致命并发症:一例报告并文献复习
Mol Clin Oncol. 2018 Oct;9(4):403-407. doi: 10.3892/mco.2018.1690. Epub 2018 Aug 2.
4
Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future.使用载药微球的经动脉化疗栓塞术治疗肝细胞癌:现状与未来。
Clin Mol Hepatol. 2015 Dec;21(4):344-8. doi: 10.3350/cmh.2015.21.4.344. Epub 2015 Dec 24.
5
Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.阿霉素洗脱微球与常规经动脉化疗栓塞治疗肝细胞癌的对比研究。
J Hepatol. 2012 Dec;57(6):1244-50. doi: 10.1016/j.jhep.2012.07.017. Epub 2012 Jul 20.
6
CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.载药微球与碘化油动脉化疗栓塞治疗肝细胞癌的短期疗效及安全性比较:一项短期疗效和安全性研究。
World J Surg Oncol. 2018 Mar 27;16(1):69. doi: 10.1186/s12957-018-1368-8.
7
Drug-Eluting Bead Transarterial Chemoembolization as Bridge Therapy for Hepatocellular Carcinoma Before Living-Donor Liver Transplantation.药物洗脱微球经动脉化疗栓塞术作为活体肝移植前肝细胞癌的桥接治疗
Transplant Proc. 2016 May;48(4):1045-8. doi: 10.1016/j.transproceed.2015.12.078.
8
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma.载药微球经动脉化疗栓塞术与传统经动脉化疗栓塞术治疗局部晚期肝细胞癌的比较
Hepat Med. 2016 Jun 20;8:69-74. doi: 10.2147/HMER.S105395. eCollection 2016.
9
Hemobilia immediately after transcatheter arterial chemoembolization using drug-eluting beads for hepatocellular carcinoma with intrahepatic bile duct invasion.经导管动脉化疗栓塞术使用载药微球治疗伴有肝内胆管侵犯的肝细胞癌后立即发生的胆道出血。
Hepatol Res. 2018 Mar;48(4):329-332. doi: 10.1111/hepr.12995. Epub 2017 Nov 22.
10
Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting.在实际临床环境中肝细胞癌的碘油灌注与载药微球经动脉化疗栓塞术的比较
Scand J Gastroenterol. 2019 Jul;54(7):905-912. doi: 10.1080/00365521.2019.1632925. Epub 2019 Jul 9.

引用本文的文献

1
Advanced targeted microsphere embolization for arteriovenous malformations: state-of-the-art and future directions.用于动静脉畸形的先进靶向微球栓塞术:现状与未来方向。
Neuroradiology. 2025 Apr;67(4):1009-1022. doi: 10.1007/s00234-025-03584-3. Epub 2025 Mar 15.
2
Delayed gastric perforation following transarterial chemoembolization: Case report.经动脉化疗栓塞术后延迟性胃穿孔:病例报告
Int J Surg Case Rep. 2023 Mar;104:107965. doi: 10.1016/j.ijscr.2023.107965. Epub 2023 Mar 4.
3
Tumor Growth Suppression With Novel Intra-arterial Chemotherapy Using Epirubicin-entrapped Water-in-oil-in-water Emulsion .

本文引用的文献

1
Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion.肝细胞癌经动脉化疗栓塞术后的肝脏和胆道损伤:载药微球与碘油乳剂的比较
Eur Radiol. 2017 Apr;27(4):1431-1439. doi: 10.1007/s00330-016-4488-y. Epub 2016 Jul 19.
2
Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future.使用载药微球的经动脉化疗栓塞术治疗肝细胞癌:现状与未来。
Clin Mol Hepatol. 2015 Dec;21(4):344-8. doi: 10.3350/cmh.2015.21.4.344. Epub 2015 Dec 24.
3
A lethal complication after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.
新型表阿霉素载水型油包水型乳剂经动脉内化疗抑制肿瘤生长。
In Vivo. 2021 Jan-Feb;35(1):239-248. doi: 10.21873/invivo.12252.
4
Transcatheter Arterial Embolization Using Microspheres for Palliating Pain from Bone Metastasis in a Patient with Cholangiocellular Carcinoma.经导管动脉栓塞术用微球治疗胆管细胞癌患者骨转移疼痛。
Intern Med. 2021 Jan 15;60(2):241-246. doi: 10.2169/internalmedicine.5351-20. Epub 2020 Sep 12.
5
Comparison of chemoembolization with CalliSpheres microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study.载药微球化疗栓塞与传统化疗栓塞治疗肝细胞癌的疗效比较:一项多中心回顾性研究
Cancer Manag Res. 2020 Feb 10;12:941-956. doi: 10.2147/CMAR.S187203. eCollection 2020.
6
Update on Transarterial Chemoembolization with Drug-Eluting Microspheres for Hepatocellular Carcinoma.经载药微球的经动脉化疗栓塞术治疗肝细胞癌的最新进展。
Korean J Radiol. 2019 Jan;20(1):34-49. doi: 10.3348/kjr.2018.0088. Epub 2018 Dec 27.
7
Ischemic Duodenal Ulceration after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Case Report.肝细胞癌经动脉化疗栓塞术后发生缺血性十二指肠溃疡:一例报告
Case Rep Gastroenterol. 2018 Jun 28;12(2):352-359. doi: 10.1159/000490604. eCollection 2018 May-Aug.
经动脉化疗栓塞联合载药微球治疗肝细胞癌后的致命并发症。
Case Rep Surg. 2015;2015:873601. doi: 10.1155/2015/873601. Epub 2015 Feb 23.
4
DC Bead Transarterial Chemoembolization Is Effective in Hepatocellular Carcinoma Refractory to Conventional Transarteral Chemoembolization: A Pilot Study.DC 微球经动脉化疗栓塞术治疗常规经动脉化疗栓塞术抵抗的肝细胞癌:一项初步研究。
Gut Liver. 2013 Jan;7(1):89-95. doi: 10.5009/gnl.2013.7.1.89. Epub 2013 Jan 11.
5
Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury.药物洗脱微球化疗栓塞治疗肝神经内分泌转移瘤的 II 期研究:高发生率的胆道损伤。
Cardiovasc Intervent Radiol. 2013 Apr;36(2):449-59. doi: 10.1007/s00270-012-0424-y. Epub 2012 Jun 22.
6
Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads.内分沁肿瘤和肝细胞癌化学栓塞术后的肝/胆损伤:碘油与载药微球。
J Hepatol. 2012 Mar;56(3):609-17. doi: 10.1016/j.jhep.2011.09.012. Epub 2011 Oct 23.
7
Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients.序贯经导管化疗栓塞联合 DC BeadTM 的安全性:237 例肝细胞癌(HCC)患者的结果。
Cardiovasc Intervent Radiol. 2011 Aug;34(4):774-85. doi: 10.1007/s00270-010-0044-3. Epub 2010 Dec 24.
8
Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.多柔比星洗脱微球栓塞治疗肝细胞癌的前瞻性随机研究:PRECISION V 研究结果。
Cardiovasc Intervent Radiol. 2010 Feb;33(1):41-52. doi: 10.1007/s00270-009-9711-7. Epub 2009 Nov 12.
9
Benefit of downsizing hepatocellular carcinoma in a liver transplant population.肝癌在肝移植人群中缩小的获益。
Aliment Pharmacol Ther. 2010 Feb 1;31(3):415-23. doi: 10.1111/j.1365-2036.2009.04167.x. Epub 2009 Oct 12.
10
Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma.经动脉化疗栓塞治疗肝细胞癌后肝动脉损伤的血管造影评估
Radiat Med. 2008 May;26(4):206-12. doi: 10.1007/s11604-007-0216-5. Epub 2008 May 29.